A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder.
- 15 September 2004
- journal article
- clinical trial
- Published by Physicians Postgraduate Press, Inc in The Journal of Clinical Psychiatry
- Vol. 65 (9) , 1190-1196
- https://doi.org/10.4088/jcp.v65n0906
Abstract
Escitalopram is the most selective serotonin reuptake inhibitor (SRI) antidepressant available. Venlafaxine is a non-selective SRI that also inhibits noradrenergic re-uptake. This study compared escitalopram and venlafaxine extended release (XR) in depressed outpatients at the highest doses recommended in the United States.Keywords
This publication has 0 references indexed in Scilit: